110 related articles for article (PubMed ID: 36735119)
1. Proteus mirabilis isolated from untreated hospital wastewater, Ibadan, Southwestern Nigeria showed low-level resistance to fluoroquinolone and carried qnrD3 on Col3M plasmids.
Ajayi-Odoko AO; Ayansina ADV; Ikhimiukor OO; Müller JA; Adelowo OO
Environ Sci Pollut Res Int; 2023 Apr; 30(16):47158-47167. PubMed ID: 36735119
[TBL] [Abstract][Full Text] [Related]
2. Molecular drivers of emerging multidrug resistance in Proteus mirabilis clinical isolates from Algeria.
Boudjemaa H; Allem R; Fonkou MDM; Zouagui S; Khennouchi NCEH; Kerkoud M
J Glob Antimicrob Resist; 2019 Sep; 18():249-256. PubMed ID: 30797091
[TBL] [Abstract][Full Text] [Related]
3. Integrons, β-lactamase and qnr genes in multidrug resistant clinical isolates of Proteus mirabilis and P. vulgaris.
Mokracka J; Gruszczyńska B; Kaznowski A
APMIS; 2012 Dec; 120(12):950-8. PubMed ID: 23030307
[TBL] [Abstract][Full Text] [Related]
4. First report in Africa of two clinical isolates of Proteus mirabilis carrying Salmonella genomic island (SGI1) variants, SGI1-PmABB and SGI1-W.
Soliman AM; Ahmed AM; Shimamoto T; El-Domany RA; Nariya H; Shimamoto T
Infect Genet Evol; 2017 Jul; 51():132-137. PubMed ID: 28359833
[TBL] [Abstract][Full Text] [Related]
5. Characterization of multidrug-resistant Proteus mirabilis isolated from chicken carcasses.
Wong MH; Wan HY; Chen S
Foodborne Pathog Dis; 2013 Feb; 10(2):177-81. PubMed ID: 23351030
[TBL] [Abstract][Full Text] [Related]
6. [Characteristic of fluoroquinolone resistant clinical isolates of K. pneumoniae, P. mirabilis and E. coli producing ESBL and AmpC beta-lactamases].
Rzeczkowska M; Piekarska K; Gierczyński R
Med Dosw Mikrobiol; 2012; 64(4):285-95. PubMed ID: 23484420
[TBL] [Abstract][Full Text] [Related]
7. Dissemination of blaOXA-58 in Proteus mirabilis isolates from Germany.
Lange F; Pfennigwerth N; Gerigk S; Gohlke F; Oberdorfer K; Purr I; Wohanka N; Roggenkamp A; Gatermann SG; Kaase M
J Antimicrob Chemother; 2017 May; 72(5):1334-1339. PubMed ID: 28093482
[TBL] [Abstract][Full Text] [Related]
8. Dissemination of a Multidrug-Resistant VIM-1- and CMY-99-Producing Proteus mirabilis Clone in Bulgaria.
Markovska R; Schneider I; Keuleyan E; Ivanova D; Lesseva M; Stoeva T; Sredkova M; Bauernfeind A; Mitov I
Microb Drug Resist; 2017 Apr; 23(3):345-350. PubMed ID: 27341161
[TBL] [Abstract][Full Text] [Related]
9. Dissemination of Multidrug-Resistant Proteus mirabilis Clones Carrying a Novel Integron-Borne
Ramos AC; Cayô R; Carvalhaes CG; Jové T; da Silva GP; Sancho FMP; Chagas-Neto T; Medeiros EAS; Gales AC
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158274
[TBL] [Abstract][Full Text] [Related]
10. Emergence of New Delhi metallo-β-lactamase 1 (NDM-1) producing and multidrug resistant uropathogens causing urinary tract infections in Andaman Islands, India.
Bhattacharya D; Thamizhmani R; Bhattacharya H; Sayi DS; Muruganandam N; Roy S; Sugunan AP
Microb Drug Resist; 2013 Dec; 19(6):457-62. PubMed ID: 23862639
[TBL] [Abstract][Full Text] [Related]
11. Extended Spectrum Beta-Lactamase (ESBL)-producing bacteria isolated from hospital wastewaters, rivers and aquaculture sources in Nigeria.
Adelowo OO; Caucci S; Banjo OA; Nnanna OC; Awotipe EO; Peters FB; Fagade OE; Berendonk TU
Environ Sci Pollut Res Int; 2018 Jan; 25(3):2744-2755. PubMed ID: 29139076
[TBL] [Abstract][Full Text] [Related]
12. First report of bla
Leulmi Z; Kandouli C; Mihoubi I; Benlabed K; Lezzar A; Rolain JM
J Glob Antimicrob Resist; 2019 Mar; 16():125-129. PubMed ID: 30217548
[TBL] [Abstract][Full Text] [Related]
13. Study of the molecular characteristics and homology of carbapenem-resistant
Liu M; Li D; Jia W; Ma J; Zhao X
J Med Microbiol; 2023 Jan; 72(1):. PubMed ID: 36748625
[No Abstract] [Full Text] [Related]
14. Genomic characterisation of a Proteus mirabilis clinical isolate from China carrying bla
Sun L; Xu J; He F
J Glob Antimicrob Resist; 2019 Dec; 19():317-319. PubMed ID: 31698108
[TBL] [Abstract][Full Text] [Related]
15. Regional outbreak of CTX-M-2 β-lactamase-producing Proteus mirabilis in Japan.
Nakano R; Nakano A; Abe M; Inoue M; Okamoto R
J Med Microbiol; 2012 Dec; 61(Pt 12):1727-1735. PubMed ID: 22935848
[TBL] [Abstract][Full Text] [Related]
16. Emergence of multidrug-resistant Proteus mirabilis in a long-term care facility in Croatia.
Bedenić B; Firis N; Elveđi-Gašparović V; Krilanović M; Matanović K; Štimac I; Luxner J; Vraneš J; Meštrović T; Zarfel G; Grisold A
Wien Klin Wochenschr; 2016 Jun; 128(11-12):404-13. PubMed ID: 27220339
[TBL] [Abstract][Full Text] [Related]
17. Role of type II topoisomerase mutations and AcrAB efflux pump in fluoroquinolone-resistant clinical isolates of Proteus mirabilis.
Saito R; Sato K; Kumita W; Inami N; Nishiyama H; Okamura N; Moriya K; Koike K
J Antimicrob Chemother; 2006 Sep; 58(3):673-7. PubMed ID: 16870650
[TBL] [Abstract][Full Text] [Related]
18. Chromosomal location of the fosA3 and bla
He D; Liu L; Guo B; Wu S; Chen X; Wang J; Zeng Z; Liu JH
Int J Antimicrob Agents; 2017 Apr; 49(4):443-448. PubMed ID: 28238801
[TBL] [Abstract][Full Text] [Related]
19. Extended-spectrum β-lactamase-producing Proteus mirabilis with multidrug resistance isolated from raw chicken in Singapore: Genotypic and phenotypic analysis.
Guo S; Aung KT; Tay MYF; Seow KLG; Ng LC; Schlundt J
J Glob Antimicrob Resist; 2019 Dec; 19():252-254. PubMed ID: 31639544
[TBL] [Abstract][Full Text] [Related]
20. Identification of plasmid-encoded extended spectrum beta-lactamases produced by a clinical strain of Proteus mirabilis.
Mahrouki S; Ben-Achour N; Chouchani C; Ben-Moussa M; Belhadj O
Pathol Biol (Paris); 2009 May; 57(3):e55-9. PubMed ID: 18456422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
